RECRUITINGPhase 4INTERVENTIONAL
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
About This Trial
The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Who May Be Eligible (Plain English)
Who May Qualify:
- chromosomal deletion proven by FISH examination
Who Should NOT Join This Trial:
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* chromosomal deletion proven by FISH examination
Exclusion Criteria:
Treatments Being Tested
DRUG
methylphenidate, fluoxetin, risperidone
first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate
Locations (1)
Schneider Children's Mediac Center of Israel
Petah Tikva, Israel